Visual electrophysiology company LKC Technologies reported on Friday the launch of its partnership with US Retina, one of the largest associations of private retina practices in the US with 203 member practices representing over 1,000 physicians, Group Purchasing Organisation (GPO).
US Retina reportedly provides valuable and immediate access to LKC's new technologies to advance the former's quality patient care, according to Peter L. Sonkin, MD, US Retina Board Member and Retinal Specialist at Tennessee Retina.
Helping the way physicians detect, diagnose and treat vision threatening diseases is the goal of every US Retina's retinal physician and LKC Technologies is the perfect partner to help US Retina's members gain access to high quality electrodiagnostic devices wherever they practice, added Dr L. Sonkin.
LKC is developing systems to provide objective functional information assisting in effective diagnosis of many ophthalmic conditions and vision threatening diseases. US Retina's vision is to lead the Retinal Vitreous industry toward high-quality and cost-effective healthcare, creating outcomes that exceed the expectations of its members, partners and patients.
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix
Organon to sell JADA System to Laborie for up to USD465m
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Oticon launches Oticon Zeal, a discreet, fully featured in-the-ear hearing aid
Halozyme Therapeutics announces Q3 2025 release date
Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia